Mycoses

Wiley
Wiley
ISSN: 09337407, 14390507

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q1
WOS
Q2
Impact factor
4.1
SJR
0.966
CiteScore
10.0
Categories
Dermatology
Medicine (miscellaneous)
Infectious Diseases
Areas
Medicine
Years of issue
1957-2025
journal names
Mycoses
Publications
8 017
Citations
84 471
h-index
89
Top-3 citing journals
Mycoses
Mycoses (8559 citations)
Journal of Fungi
Journal of Fungi (2938 citations)
Medical Mycology
Medical Mycology (2928 citations)
Top-3 countries
Germany (1265 publications)
USA (507 publications)
India (422 publications)

Most cited in 5 years

Found 
from chars
Publications found: 277
The effect of ghrelin on antioxidant status in the rat’s model of Alzheimer's disease induced by amyloid-beta
Sarlaki F., Shahsavari Z., Goshadrou F., Naseri F., Keimasi M., Sirati-Sabet M.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 11
Open Access
Open access
Is autologous platelet activation the key step in ovarian therapy for fertility recovery and menopause reversal?
Rickers N.S., Sills E.S.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 4
Open Access
Open access
Crosstalk between Fatty Acid Metabolism and Tumour-Associated Macrophages in Cancer Progression
Zaidi N.E., Shazali N.A., Leow T.C., Osman M.A., Ibrahim K., Rahman N.M.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 12
Open Access
Open access
The expression of ACAT1 in oral squamous cell carcinoma and the adjacent pre-tumour tissue
Firouzpour H., Shokrolahi S.M., Bourova-Flin E., Derakhshan S., Shahsavari Z., Karimi A., Mir Mohammad Sadeghi H., Goudarzi A.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 4
Open Access
Open access
In silico and in vitro studies of Taiwan Chingguan Yihau (NRICM101) on TNF-α/IL-1β-induced Human Lung Cells
Cheng Y., Lu C., Hsu Y., Tsai F., Bau D., Tsai S., Cheng C., Lin J., Huang Y., Juan Y., Chiu Y., Kuo S., Yang J., Wu L.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 10
Open Access
Open access
The evaluation of serum lipid profile and Apolipoprotein C-1 in the Iranian patients of Oral Squamous Cell Carcinoma
Alazzawi W., Shahsavari Z., Babaei H., Firouzpour H., Karimi A., Goudarzi A.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 2
Open Access
Open access
LEP G2548A Polymorphism is Associated with Increased Serum Leptin and Insulin Resistance among T2DM Malaysian Patients
Ali L.A., Jemon K., Ab Latif N., Abu Bakar S., Syed Alwi S.S.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 2
Open Access
Open access
Fibroblast Growth Factor Receptor 1-Bound Extracellular Vesicle as Novel Therapy for Osteoarthritis
Liyis B.G., Nolan J., Maharjana M.A.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 16
Open Access
Open access
Serum alpha-1-antitrypsin level in the severity prognosis of systemic lupus erythematosus patients: Systematic exploration of novel biomarker
Khamchun S., Thakaeng C., Na Lampang R.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 3
Open Access
Open access
Oral administration of injectable vitamin K1 in Brodifacoum intoxication
Chu Y., Lin J., Hung D.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 2
Open Access
Open access
Comparison between the analytical sensitivity and clinical performance of two cobas SARS-CoV-2 tests based on high-throughput and point-of-care systems
Lin T., Bui N., Chang Y., Hsu L., Su Y., Chang C., Hong W., Le U.N., Huang S., Lin C.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 5
Open Access
Open access
Anti-Herpes Virus Activity Of Lactobacillus’ Postbiotics
Vilhelmova_Ilieva N., Atanasov G., Simeonova L., Dobreva L., Mancheva K., Trepechova M., Danova S.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 13
Open Access
Open access
Applying Artificial Neural-network Model to Predict Psychiatric Symptoms
Allahyari E., Roustaei N.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 8
Open Access
Open access
Study of the D-dimer, C-reactive protein, and autoantibodies markers among HBV infected patients in Babylon province, Iraq
Bayram A.A., Al-Dahmoshi H.O., Al-Khafaji N.S., Al Mammori R.T., Al-Shimmery A.H., Saki M.
Q2
Elsevier
BioMedicine (Netherlands) 2021 citations by CoLab: 3
Open Access
Open access

Top-100

Citing journals

1000
2000
3000
4000
5000
6000
7000
8000
9000
Show all (70 more)
1000
2000
3000
4000
5000
6000
7000
8000
9000

Citing publishers

2000
4000
6000
8000
10000
12000
14000
16000
18000
Show all (70 more)
2000
4000
6000
8000
10000
12000
14000
16000
18000

Publishing organizations

20
40
60
80
100
120
Show all (70 more)
20
40
60
80
100
120

Publishing organizations in 5 years

5
10
15
20
25
30
35
40
45
Show all (70 more)
5
10
15
20
25
30
35
40
45

Publishing countries

200
400
600
800
1000
1200
1400
Germany, 1265, 15.78%
USA, 507, 6.32%
India, 422, 5.26%
Italy, 347, 4.33%
Brazil, 333, 4.15%
China, 255, 3.18%
Netherlands, 228, 2.84%
Japan, 198, 2.47%
Spain, 192, 2.39%
France, 191, 2.38%
Turkey, 181, 2.26%
United Kingdom, 173, 2.16%
Austria, 151, 1.88%
Belgium, 148, 1.85%
Iran, 135, 1.68%
Poland, 125, 1.56%
Switzerland, 119, 1.48%
Hungary, 113, 1.41%
Greece, 98, 1.22%
Israel, 95, 1.18%
Czech Republic, 95, 1.18%
Sweden, 86, 1.07%
Nigeria, 66, 0.82%
Egypt, 64, 0.8%
Canada, 64, 0.8%
Republic of Korea, 58, 0.72%
Russia, 55, 0.69%
Mexico, 51, 0.64%
Finland, 46, 0.57%
Thailand, 45, 0.56%
Denmark, 44, 0.55%
Australia, 43, 0.54%
Argentina, 35, 0.44%
Portugal, 34, 0.42%
Kuwait, 34, 0.42%
Romania, 31, 0.39%
Slovakia, 30, 0.37%
Saudi Arabia, 28, 0.35%
Venezuela, 20, 0.25%
Colombia, 20, 0.25%
Tunisia, 20, 0.25%
Oman, 19, 0.24%
Serbia, 18, 0.22%
Croatia, 18, 0.22%
Czechoslovakia, 18, 0.22%
Bulgaria, 16, 0.2%
Malaysia, 15, 0.19%
Iraq, 14, 0.17%
Ireland, 13, 0.16%
South Africa, 13, 0.16%
Sudan, 12, 0.15%
Yugoslavia, 12, 0.15%
Bosnia and Herzegovina, 11, 0.14%
Indonesia, 11, 0.14%
Chile, 11, 0.14%
Jordan, 10, 0.12%
Pakistan, 10, 0.12%
Peru, 10, 0.12%
Uganda, 10, 0.12%
USSR, 10, 0.12%
Kenya, 9, 0.11%
Slovenia, 9, 0.11%
Lebanon, 8, 0.1%
Norway, 7, 0.09%
Cuba, 6, 0.07%
UAE, 6, 0.07%
Algeria, 5, 0.06%
Vietnam, 5, 0.06%
Qatar, 5, 0.06%
New Zealand, 5, 0.06%
Sri Lanka, 5, 0.06%
Guatemala, 4, 0.05%
Honduras, 4, 0.05%
Singapore, 4, 0.05%
Estonia, 3, 0.04%
Gabon, 3, 0.04%
Cameroon, 3, 0.04%
Costa Rica, 3, 0.04%
Malta, 3, 0.04%
Nepal, 3, 0.04%
Palestine, 3, 0.04%
Senegal, 3, 0.04%
Ukraine, 2, 0.02%
Bolivia, 2, 0.02%
Zimbabwe, 2, 0.02%
Iceland, 2, 0.02%
Cambodia, 2, 0.02%
Democratic Republic of the Congo, 2, 0.02%
Côte d'Ivoire, 2, 0.02%
Libya, 2, 0.02%
Lithuania, 2, 0.02%
Panama, 2, 0.02%
Paraguay, 2, 0.02%
Tanzania, 2, 0.02%
Togo, 2, 0.02%
Uruguay, 2, 0.02%
Philippines, 2, 0.02%
Belarus, 1, 0.01%
Afghanistan, 1, 0.01%
Bangladesh, 1, 0.01%
Show all (70 more)
200
400
600
800
1000
1200
1400

Publishing countries in 5 years

20
40
60
80
100
120
USA, 110, 15.13%
China, 100, 13.76%
India, 86, 11.83%
Brazil, 75, 10.32%
Germany, 72, 9.9%
Netherlands, 62, 8.53%
Iran, 51, 7.02%
Spain, 45, 6.19%
Italy, 39, 5.36%
France, 36, 4.95%
United Kingdom, 32, 4.4%
Austria, 25, 3.44%
Turkey, 23, 3.16%
Switzerland, 22, 3.03%
Japan, 22, 3.03%
Belgium, 15, 2.06%
Israel, 13, 1.79%
Mexico, 12, 1.65%
Republic of Korea, 12, 1.65%
Canada, 11, 1.51%
Greece, 9, 1.24%
Denmark, 9, 1.24%
Argentina, 8, 1.1%
Colombia, 8, 1.1%
Thailand, 8, 1.1%
Russia, 7, 0.96%
Australia, 7, 0.96%
Egypt, 7, 0.96%
Nigeria, 7, 0.96%
Pakistan, 7, 0.96%
Sweden, 7, 0.96%
Poland, 6, 0.83%
Uganda, 6, 0.83%
Portugal, 5, 0.69%
Indonesia, 5, 0.69%
Ireland, 5, 0.69%
Oman, 5, 0.69%
Serbia, 5, 0.69%
Sudan, 5, 0.69%
Hungary, 4, 0.55%
Honduras, 4, 0.55%
Romania, 4, 0.55%
Czech Republic, 4, 0.55%
Bulgaria, 3, 0.41%
Guatemala, 3, 0.41%
Saudi Arabia, 3, 0.41%
Finland, 3, 0.41%
Chile, 3, 0.41%
South Africa, 3, 0.41%
Kenya, 2, 0.28%
Democratic Republic of the Congo, 2, 0.28%
Kuwait, 2, 0.28%
Lebanon, 2, 0.28%
Croatia, 2, 0.28%
Algeria, 1, 0.14%
Afghanistan, 1, 0.14%
Bangladesh, 1, 0.14%
Bahrain, 1, 0.14%
Bolivia, 1, 0.14%
Bosnia and Herzegovina, 1, 0.14%
Burkina Faso, 1, 0.14%
Venezuela, 1, 0.14%
Vietnam, 1, 0.14%
Cambodia, 1, 0.14%
Cameroon, 1, 0.14%
Qatar, 1, 0.14%
Kyrgyzstan, 1, 0.14%
Congo-Brazzaville, 1, 0.14%
Costa Rica, 1, 0.14%
Côte d'Ivoire, 1, 0.14%
Malaysia, 1, 0.14%
Nepal, 1, 0.14%
Nicaragua, 1, 0.14%
Norway, 1, 0.14%
UAE, 1, 0.14%
Panama, 1, 0.14%
Paraguay, 1, 0.14%
Peru, 1, 0.14%
El Salvador, 1, 0.14%
Senegal, 1, 0.14%
Singapore, 1, 0.14%
Slovenia, 1, 0.14%
Togo, 1, 0.14%
Philippines, 1, 0.14%
Ecuador, 1, 0.14%
Show all (55 more)
20
40
60
80
100
120